Garin, E.; Palard, X.; Rolland, Y.; Le Sourd, S.; Lepareur, N.; Ardisson, V.; Bouvry, C.; Laffont, S.; Campillo-Gimenez, B.; Bellissant, E.;
et al. 188Re-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study). Cancers 2023, 15, 2245.
https://doi.org/10.3390/cancers15082245
AMA Style
Garin E, Palard X, Rolland Y, Le Sourd S, Lepareur N, Ardisson V, Bouvry C, Laffont S, Campillo-Gimenez B, Bellissant E,
et al. 188Re-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study). Cancers. 2023; 15(8):2245.
https://doi.org/10.3390/cancers15082245
Chicago/Turabian Style
Garin, Etienne, Xavier Palard, Yan Rolland, Samuel Le Sourd, Nicolas Lepareur, Valérie Ardisson, Christelle Bouvry, Sophie Laffont, Boris Campillo-Gimenez, Eric Bellissant,
and et al. 2023. "188Re-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study)" Cancers 15, no. 8: 2245.
https://doi.org/10.3390/cancers15082245
APA Style
Garin, E., Palard, X., Rolland, Y., Le Sourd, S., Lepareur, N., Ardisson, V., Bouvry, C., Laffont, S., Campillo-Gimenez, B., Bellissant, E., & Edeline, J.
(2023). 188Re-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study). Cancers, 15(8), 2245.
https://doi.org/10.3390/cancers15082245